(19)
(11) EP 1 097 129 A1

(12)

(43) Date of publication:
09.05.2001 Bulletin 2001/19

(21) Application number: 99936567.9

(22) Date of filing: 19.07.1999
(51) International Patent Classification (IPC)7C07C 311/20, C07C 233/80, C07C 235/56, C07D 261/18, C07D 333/34, C07D 333/24, C07C 233/65, C07C 235/42, C07D 213/82, A61K 31/18, A61K 31/27, A61K 31/38, A61K 31/42, A61K 31/44
(86) International application number:
PCT/EP9905/131
(87) International publication number:
WO 0005/201 (03.02.2000 Gazette 2000/05)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 21.07.1998 US 120017

(71) Applicants:
  • Novartis AG
    4058 Basel (CH)

    BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE CY 
  • Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.
    1230 Wien (AT)

    AT 

(72) Inventors:
  • FINK, Cynthia, Anne
    Lebanon, NJ 08833 (US)
  • KSANDER, Gary, Michael
    Milford, NJ 08848 (US)
  • KUKKOLA, Paivi, Jaana
    Whitehouse Station, NJ 08889 (US)
  • WALLACE, Eli, Melville
    Chapel Hill, NC 27516 (US)

(74) Representative: Becker, Konrad 
Novartis AGCorporate Intellectual PropertyPatent- und Markenabteilung
4002 Basel
4002 Basel (CH)

   


(54) N-BENZOCYCLOALKYL-AMIDE DERIVATIVES AND THEIR USE AS MEDICAMENTS